Saint Luke's Cancer Institute的动态

Victorian Cancer Plan 2024-2028 ? Released last week, the Victorian Cancer Plan outlines the Victorian Government’s objectives and policy priorities, also?highlighting their progress against the goals of the Victorian Cancer Plan 2020-2024. The 2024-2028 Plan will target 2 key priority areas:? ?? Greater equity in access to cancer prevention, treatment and supportive care;? ?? Renewed focus on cancer screening and early detection PC4 is very supportive of a coordinated and collaborative approach to achieve better cancer outcomes for all Victorians. In particular, the enormous gains that can be made through improving early detection of disease is a strong focus for PC4 and our members. It is great to see this corresponding alignment with the objectives of Victorian’s Cancer Plan. https://lnkd.in/gFR9qFMc

November is Lung Cancer Awareness Month, a time to highlight the critical work being done to address this disease, which has the highest mortality rate both nationally and in our catchment area. Over the last five years, advances in early detection, immunotherapy, and targeted treatments have begun to shift the landscape of lung cancer care. Today, we’re better equipped to diagnose lung cancer at its early stages, when it’s most treatable. New surgical techniques now allow for less invasive procedures, preserving lung function and improving recovery for patients. This progress represents a significant step forward, yet challenges remain. Lung cancer’s five-year survival rate still hovers around 25%, making research and early intervention crucial. The Cancer Center is tackling these challenges with a comprehensive approach. Through community outreach and education, cutting-edge research, and innovative treatments, we are working to reduce lung cancer’s toll. Join us in recognizing Lung Cancer Awareness Month and stay tuned to learn more about how we’re advancing lung cancer research.

On February 4, the world once again united to raise awareness, improve education, and catalyze action in the fight against cancer on World Cancer Day. The theme, “Close the Care Gap,” speaks to us at AccessHope. Our mission is to deploy the latest cancer knowledge to the places it is needed most, when it is most valuable – thereby closing the gap for the people we serve. Read more in our blog to see how we’re using renowned knowledge and expertise to fight cancer with everything we know today, and every day. https://hubs.la/Q02jVxdf0

Towards the end of last year, there was a Boston-area Cancer Care shakeup when Dana-Farber Cancer Institute announced plans to open a new facility and sunset a decades-old relationship. Mass General Brigham popped up in the news in the past week, unveiling their plans for Mass General Brigham Cancer in response to the changing landscape. The monumental task of reimagining a cancer care program also presents significant opportunity to part ways with approaches that become ingrained over time, making way for innovation that drives equity and outcomes. While there's still a multi-year journey ahead, the strategic pillars of Equity, Early Diagnosis, Rapid Intake, Integrated and Longitudinal Care, Innovation, and Research-Driven Treatment are encouraging. As the team continues to flesh out the people, operations, space, and capabilities that will differentiate them, I hope patient transportation is a consideration. While home-based care opportunities are growing, common cancer treatments like radiation can require daily in-person visits, which can be taxing on friends/family of well-supported patients, and a total showstopper for patients who lack that support. Programs like American Cancer Society's Road to Recovery aim to help ease that burden, however MGB has an interesting opportunity to design access into their Equity pillar from Day 0.

On this #worldcancerday, we must address the critical need for holistic survivorship care for those living with and beyond cancer. This special section of the Journal of Cancer Survivorship (edited by Sharon Manne and myself) highlights the history of survivorship programs at eight US cancer centers. Despite the notable challenges, each center achieved major accomplishments and there’s much to be learned from their experiences. https://lnkd.in/e6DgEybA https://lnkd.in/ey4Aqtw2 Dana-Farber Cancer Institute UCLA Jonsson Comprehensive Cancer Center Roswell Park Comprehensive Cancer Center St. Jude Children's Research Hospital Masonic Cancer Center, University of Minnesota ROBERT H. LURIE COMPREHENSIVE CANCER CENTER OF NORTHWESTERN UNIVERSITY Abramson Cancer Center of the University of Pennsylvania Stanford Cancer Institute As these cancer center programs were specifically chosen for this special series, we must also understand the experiences of community-based programs (where most cancer survivors receive their care) and programs outside the US (in both high-income and low- and middle-income countries). The population of cancer survivors is growing, including individuals living with advanced and metastatic cancer. In addition to offering state of the art cancer treatment, cancer centers must implement survivorship care services that address the complex needs of the growing and diverse population of cancer survivors, educate and train a multidisciplinary and multispecialty workforce to care for them, and actively collaborate with advocacy groups and community-based organizations to expand reach. #cancercare #cancersurvivorship #cancer #cancersurvivor

When we hear the word cancer, our world changes forever and our lives comes to a standstill. Carefree days with jovial pursuits are replaced with doctor's appointments, reading and gaining more knowledge of the disease and its treatments and maintaining a positive attitude while having a huge pit in your stomach everyday. This was my life when on January 22, 2004 my mom was diagnosed with cervical cancer at the age of 78. My twin sister and I as her primarily caregivers split our work schedules so one of us would be with her 24/7. This was in the days before remote work and smart phones. So to say we were effected emotionally as well as professionally is an understatement. And seeing my mom the strongest woman I've ever known suffer was devastating. When she passed on May 10, 2005, I loss my best friend. I lived the next 8 years in a blur having many extreme hardships. Accepting a temporary position in 2013 through a staffing agency for a Clinical Trial Assistant lead me to Premier Research and thus began my clinical trials career and my passion for clinical research. Being on the patient's family side gives me a deep empathy and understanding for what they go through because I've lived it. It's a honor and privilege to be able to contribute to clinical trials through my role as a Principle Records Specialist. Every study team and project I'm assigned to is meaningful as I know the work we doing is helping to improve lives. World Cancer Day allows us to support and acknowledge the toll cancer takes. This is why World Cancer Day matters to me. #WorldCancerDay #WorkCancerDay2024 #ClinicalResearch #ClinicalTrials #PremierPeople #PremierResearch

Navigating our global efforts to reduce the impact and burden of cancer will present both significant challenges and opportunities. In this blog, I share my thoughts on how we need to work together to address the rising cancer incidence and mortality. Union for International Cancer Control (UICC) Cancerfonden https://lnkd.in/dYNZNmvY

We’re thrilled to announce the winners of the 2024 Lung Ambition Awards. Dr. Fei Geng, leading a team at McMaster University in Hamilton, is working towards revolutionizing lung cancer screening by developing and evaluating a new blood-based test with the potential to cost-effectively screen more people with the goal of detecting more lung cancers earlier. Dr. Natasha Leighl, leading a team at Princess Margaret Cancer Centre in Toronto, is incorporating liquid biopsies (a simple blood draw) into care for patients with advanced lung cancer. Two sets of patient groups will have access to liquid biopsies – those who need more information about their cancer’s molecular profile and those who have stopped responding to a targeted treatment. The liquid biopsy results can help determine the patient’s most effective treatment and start it more quickly. Each winner will be awarded $50,000 CAD to support their research. The Lung Ambition Awards is a joint initiative from Lung Cancer Canada, The Lung Ambition Alliance and AstraZeneca Canada to support Canadian-based lung cancer research that will help address key gaps in lung cancer care, drive meaningful improvements to the patient pathway and make the lives of people living with lung cancer better. Watch the video here: https://lnkd.in/gy5TTcra AstraZeneca Lung Ambition Alliance

“Incidence is increasing for many common cancers, including 6 of the top 10,” according to the American Cancer Society. But there has not been a lack of cancer conferences, walks, runs, and galas over the past couple decades. Something isn’t working. Maybe we need to look at preventing and curing cancer differently. Let’s start by being honest about cancer. The CURE story link: https://lnkd.in/gm7ZZ-zJ #cancer #preventcancer #breastcancer #cancersucks #hereditarycancer #preventcancer #1forcecommunity #worldovariancancerday #ovariancancer #pancreaticcancer #luekemia #braincancer #prostatecancer

Join us on 10 July for a webinar examining the crucial role of care pathways in delivering optimal lung cancer care. Despite compelling evidence supporting their efficacy, formal care pathways for lung cancer have been established in just a few countries and regions. The webinar will highlight their role in improving patient experiences and outcomes and health system efficiency, and panellists will share their real-world experiences and discuss opportunities for implementation. Leading experts from around the world will share their insights: ·Dr Anand Sachithanandan, Sunway and Subang Jaya Medical Centres, Malaysia ·Andrea Borondy Kitts, Rescue Lung Society, US ·Professor David Baldwin Baldwin, University of Nottingham, UK ·Debra Montague, Lung Cancer Europe, Switzerland ·Professor Morten Quist, University of Copenhagen, Denmark ·?Dr Zulfiquer Otty, Icon Cancer Centre, Australia Register now to find out how effective care pathways can deliver a holistic and high-quality experience for people with lung cancer. By improving outcomes and optimising the use of resources, we can ensure a better future for all those affected by lung cancer. Register now:?https://lnkd.in/etyShpQe